Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
   PubMed Web of Science ®Google Scholar
• Tu SM, Lin SH, Logothetis CJ. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol. 2002;3(8):508–513.
   PubMed Web of Science ®Google Scholar
• Hanna NH, Einhorn LH. Testicular cancer–discoveries and updates. N Engl J Med. 2014;371(21):2005–2016.
   PubMed Web of Science ®Google Scholar
• di Pietro A, Vries EG, Gietema JA, et al. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol. 2005;37(12):2437–2456.
   PubMed Web of Science ®Google Scholar
• International Prognostic Factors Study G, Lorch A, Beyer J, Bascoul-Mollevi C, et al. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol. 2010;28(33):4906–4911.
   PubMed Web of Science ®Google Scholar
• Suyama K, Yao J, Liang H, et al. An AKT3 splice variant lacking the serine 472 phosphorylation site promotes apoptosis and suppresses mammary tumorigenesis. Cancer Res. 2018;78(1):103–114.
   PubMed Web of Science ®Google Scholar
• De Vries G, Rosas-Plaza X, van Vugt M, et al. Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities. Cancer Treat Rev. 2020;88:102054.
   PubMedGoogle Scholar
• Jin Y, Tao LP, Yao SC, et al. MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3. Eur Rev Med Pharmacol Sci. 2017;21(22):5112–5120.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yang T, Ji J, et al. RHPN1-AS1 promotes cell proliferation and migration via miR-665/AKT3 in ovarian cancer. Cancer Gene Ther. 2021;28(1–2):33–41.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou Z, Zhang Q, et al. Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma. Biochem Biophys Res Commun. 2019;510(3):479–486.
   PubMed Web of Science ®Google Scholar
• Wang Y-X, Zhu H-F, Zhang Z-Y, et al. MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3. Cancer Cell Int. 2018;18(1):124.
   PubMed Web of Science ®Google Scholar
• Lin H-P, Lin C-Y, Huo C, et al. AKT3 promotes prostate cancer proliferation cells through regulation of AKT, B-Raf & TSC1/TSC2. Oncotarget. 2015;6(29):27097–27112.
   PubMedGoogle Scholar
• Hinz N, Jucker M. Distinct functions of AKT isoforms in breast cancer: a comprehensive review. Cell Commun Signal. 2019;17(1):154.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu J, Xia L, et al. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma. Cancer Sci. 2018;109(2):384–394.
   PubMed Web of Science ®Google Scholar
• Liu CJ, Hu FF, Xia MX, et al. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771–3772.
   PubMed Web of Science ®Google Scholar
• Korkola JE, Heck S, Olshen AB, et al. Development and validation of a gene-based model for outcome prediction in germ cell tumors using a combined genomic and expression profiling approach. PLoS One. 2015;10(12):e0142846.
   PubMed Web of Science ®Google Scholar
• Gyorffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J. 2021;19:4101–4109.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Fagerberg L, Hallstrom BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404.
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–D63.
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678.
   PubMed Web of Science ®Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200–4202.
   PubMed Web of Science ®Google Scholar
• Wiesehofer M, Czyrnik ED, Spahn M, et al. Increased expression of AKT3 in neuroendocrine differentiated prostate cancer cells alters the response towards anti-androgen treatment. Cancers (Basel). 2021;13:3.
   Web of Science ®Google Scholar
• Buikhuisen JY, Gomez Barila PM, Torang A, et al. AKT3 expression in mesenchymal colorectal cancer cells drives growth and is associated with epithelial-mesenchymal transition. Cancers (Basel). 2021;13:4.
   Web of Science ®Google Scholar
• Hinz N, Baranowsky A, Horn M, et al. Knockdown of AKT3 activates HER2 and DDR kinases in bone-seeking breast cancer cells, promotes metastasis in vivo and attenuates the TGFbeta/CTGF axis. Cells. 2021;10:2.
   Web of Science ®Google Scholar
• Bo H, Cao K, Tang R, et al. A network-based approach to identify DNA methylation and its involved molecular pathways in testicular germ cell tumors. J Cancer. 2019;10(4):893–902.
   PubMed Web of Science ®Google Scholar
• Li J, Bo H, Zhu F, et al. Hypomethylated SPANXA1/A2 promotes the metastasis of head and neck squamous cell carcinoma. Med Oncol. 2020;37(12):112.
   PubMed Web of Science ®Google Scholar
• Fazal Z, Singh R, Fang F, et al. Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours. Epigenetics. 2021; 16(10): 1071–1084.
   Web of Science ®Google Scholar
• Beyrouthy MJ, Garner KM, Hever MP, et al. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Cancer Res. 2009;69(24):9360–9366.
   PubMed Web of Science ®Google Scholar
• Siska PJ, Johnpulle RAN, Zhou A, et al. Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling. Oncoimmunology. 2017;6(4):e1305535.
   PubMed Web of Science ®Google Scholar
• Luo Y, Sun Y, Li L, et al. METTL3 may regulate testicular germ cell tumors through EMT and immune pathways. Cell Transplant. 2020;29:963689720946653.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ji C, Liu J, et al. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors. Int Immunopharmacol. 2020;86:106710.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Rokudai S, Kawabata-Iwakawa R, et al. AKT3 is a key regulator of head and neck squamous cell carcinoma. Cancer Sci. 2021;112(6):2325–2334.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang Z, Xiao XY, et al. Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment. Bioengineered. 2021;12(1):1939–1951.
   PubMed Web of Science ®Google Scholar
• Ji C, Wang Y, Wang Y, et al. Immune-related genes play an important role in the prognosis of patients with testicular germ cell tumor. Ann Transl Med. 2020;8(14):866.
   PubMed Web of Science ®Google Scholar